🇺🇸 FDA
Patent

US 8927495

Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia

granted A61KA61K2039/6081A61K38/09

Quick answer

US patent 8927495 (Use of GnRH and analogs thereof for the prevention and treatment of pet ferret adrenocortical hyperplasia) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/6081, A61K38/09, A61K39/0006